AGREEMENT AND PLAN OF MERGER AND REORGANIZATION dated as of December 11, 2020 by and among TURNSTONE BIOLOGICS CORP., FLATIRON MERGER SUB I, INC., FLATIRON MERGER SUB II, LLC, MYST THERAPEUTICS, INC., and TIMOTHY LANGER, solely in his capacity as...Merger Agreement • May 15th, 2023 • Turnstone Biologics Corp. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledMay 15th, 2023 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (this “Agreement”) is made and entered into as of December 11, 2020 by and among (i) Turnstone Biologics Corp., a Delaware corporation (“Parent”); (ii) Flatiron Merger Sub I, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Parent (“Merger Sub”); (iii) Flatiron Merger Sub II, LLC, a Delaware limited liability company and a direct, wholly owned subsidiary of Parent (“Merger LLC”); (iv) Myst Therapeutics, Inc., a Delaware corporation (the “Company”); and (v) Timothy Langer, solely in his capacity as the representative, agent and attorney-in-fact of the Equityholders (the “Equityholders Representative”), but solely with respect to the provisions expressly applicable to the Equityholders Representative as set forth herein (each, a “Party” and collectively the “Parties”).
AGREEMENT AND PLAN OF MERGER dated as of November 12, 2019 by and among NEXTGEN HEALTHCARE, INC. (“Parent”), RENEGADE MERGER SUB, INC. (“Merger Sub”), MEDFUSION, INC. (the “Company”), and PROJECT RENEGADE LLC (the “Equityholders Representative”), and...Merger Agreement • November 18th, 2019 • Nextgen Healthcare, Inc. • Services-computer integrated systems design • Delaware
Contract Type FiledNovember 18th, 2019 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of November 12, 2019 by and among NextGen Healthcare, Inc., a California corporation (“Parent”), Renegade Merger Sub, Inc., a Delaware corporation and an wholly-owned subsidiary of Parent (“Merger Sub”), Medfusion, Inc., a Delaware corporation (the “Company”), Project Renegade LLC, a North Carolina limited liability company (the “Equityholders Representative”) and solely for the purposes of Section 6.9, Greenlight Health Data Solutions, Inc., a Delaware corporation (“Newco”) (each, a “Party” and collectively the “Parties”).
AGREEMENT AND PLAN OF MERGER dated as of July 6, 2017 by and among ENTELLUS MEDICAL, INC. (“Parent”), STINGER MERGER SUB, INC. (“Merger Sub”), and SPIROX, INC. (the “Company”)Merger Agreement • July 7th, 2017 • Entellus Medical Inc • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledJuly 7th, 2017 Company Industry JurisdictionTHIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of July 6, 2017 by and among Entellus Medical, Inc., a Delaware corporation (“Parent”), Stinger Merger Sub, Inc., a Delaware corporation and an indirect wholly-owned subsidiary of Parent (“Merger Sub”), Spirox, Inc., a Delaware corporation (the “Company”), and Fortis Advisors LLC, a Delaware limited liability company, as the Equityholders Representative hereunder (each, a “Party” and collectively the “Parties”).